Internal Medicine Alert
RSSArticles
-
The Mediterranean Diet Plus Extra Virgin Olive Oil May Improve or Maintain Cognitive Function in Mature Adults
In an older population, a Mediterranean diet supplemented with olive oil or nuts is associated with improved cognitive function compared with controls on a low-fat diet.
-
Sleep Patterns Predict Diabetes Risk
Work schedules that interfered with sleep increased the risk of type 2 diabetes.
-
Clinical Briefs
In this section: improving cardiovascular outcomes through early treatment of diabetes; re-thinking PTSD treatment in veterans; and a link between rosacea and cardiovascular disease.
-
Flibanserin Tablets (Addyi)
The FDA has approved the first drug for the treatment of hypoactive sexual desire disorder in women.
-
The Impact of Hypoglycemia on Renal Impairment
A retrospective cohort study evaluated renal function data of 101 patients with type 2 diabetes and a history of severe hypoglycemia compared with a matched group of individuals with type 2 diabetes with no history of hypoglycemia.
-
Efficacy and Safety of Very Early Mobilization After Onset of Acute Stroke
The higher dose, very early (within 24 hours) mobilization protocol was associated with a reduction in the odds of a favorable outcome at 3 months after stroke occurrence.
-
SPRINT: The Systolic Blood Pressure Trial or ‘How Low Do You Go?’
Designed to see if lower blood pressures reduced the risk of blood pressure-related health outcomes, the NIH ended the SPRINT trial early and issued a news release that a lower blood pressure target significantly reduces cardiovascular complications in adults age 50 and older with high blood pressure.
-
ECG Review: A 43-Year-Old Man with Atypical Chest Pain
-
Clinical Briefs
In this section: reversing the anticoagulant effect of dabigatran; considering the likelihood of occult cancer causing unprovoked deep venous thrombosis; and cardiovascular autonomic neuropathy occurs earlier in type 2 diabetes.
-
Evolocumab Injection (Repatha)
Evolocumab is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in patients who require additional lowering of LDL-C.